; the functions and mechanisms by which most of these act are unknown. Herpesvirus saimiri, a γ-herpesvirus that establishes latency in the T cells of New World primates and has the ability to cause aggressive leukaemias and lymphomas in non-natural hosts 2 , expresses seven small nuclear uracil-rich non-coding RNAs (called HSURs) in latently infected cells [3] [4] [5] . These HSURs associate with Sm proteins, and share biogenesis and structural features with cellular Sm-class small nuclear RNAs 4,6 . One of these HSURs (HSUR2) base-pairs with two host cellular microRNAs (miR-142-3p and miR-16 7 ) but does not affect their abundance or activity, which suggests that its interactions with them perform alternative functions. Here we show that HSUR2 also base-pairs with mRNAs in infected cells. We combined in vivo psoralen-mediated RNA-RNA crosslinking and high-throughput sequencing to identify the mRNAs targeted by HSUR2, which include mRNAs that encode retinoblastoma and factors involved in p53 signalling and apoptosis. We show that HSUR2 represses the expression of target mRNAs and that basepairing between HSUR2 and miR-142-3p and miR-16 is essential for this repression, suggesting that HSUR2 recruits these two cellular microRNAs to its target mRNAs. Furthermore, we show that HSUR2 uses this mechanism to inhibit apoptosis. Our results uncover a role for this viral Sm-class RNA as a microRNA adaptor in the regulation of gene expression that follows precursor mRNA processing.
. They resemble the 3′ untranslated regions of mRNAs, insofar as they contain adenylate-uridylate (AU)-rich elements (AREs) [10] [11] [12] and binding sites for the host microRNAs (miRNAs) miR-27, miR-142-3p, and miR-16 7 (Extended Data Fig. 1a ). The binding of HSUR1 to miR-27 results in the degradation of this miRNA and enhances the activated state of the infected T cell 7, 13 . However, HSUR1 and HSUR2 do not affect the activity of ARE-binding proteins in virally transformed T cells 10 or the abundance or activity of miR-142-3p and miR-16 7 (Extended Data Fig. 1b) , which suggests that these HSURs do not function as inhibitors of these two miRNAs.
We hypothesized that HSUR2 regulates gene expression by basepairing with target mRNAs, and by recruiting miR-142-3p, miR-16 and ARE-binding proteins to the mRNAs it targets. We first used in vivo psoralen-mediated crosslinking of RNA-RNA interactions 14 to determine whether HSUR2 base-pairs with mRNAs in virally transformed marmoset T cells. Crosslinking with the psoralen derivative 4′ -aminomethyltrioxalen (AMT), followed by polyadenylated (polyA+ ) RNA selection, showed that HSUR2 base-pairs with polyA+ RNA in vivo (Fig. 1a) ; we did not detect similar activity among cellular spliceosomal Sm-class RNAs. HSUR2 therefore probably targets mature mRNAs rather than precursor mRNAs (pre-mRNAs). miRNAs associate with actively translated mRNAs, which can be detected using sucrose-gradient co-sedimentation with polyri bosomes 15, 16 . Fractionation of cytoplasmic extracts from HVS-transformed marmoset T cells revealed that HSUR2 co-sediments with polyribosomes, mirroring the sedimentation of the HSUR2-binding miRNAs, miR-142-3p and miR-16. By contrast, spliceosomal U2 and U6 short nuclear RNAs (snRNAs) do not co-sediment with polyribosomes (Fig. 1b) . The dissociation of polyribosomes into subunits using EDTA treatment shifted HSUR2, miRNAs, and β -actin mRNA to regions of the gradient indicative of lighter molecular weights; the presence of HSUR2 in the polyribosomal region of the gradient is therefore not a consequence of it associating with a highmolecular weight, EDTA-insensitive particle (Fig. 1c) . To test whether HSUR2 associates with translationally active mRNAs, we treated cells with the drugs puromycin or pactamycin, which inhibit protein synthesis through different mechanisms. As expected, treatment with either of these drugs disassembled polyribosomes, increased levels of 80S ribosomes, and shifted miRNAs and mRNAs to a lighter-molecular weight region of the gradient (Fig. 1d) . HSUR2 exhibited the same shift, indicating that it associates with translating mRNAs (Fig. 1d) .
We developed a method to identify mRNAs directly bound by HSUR2, which we termed RNA-RNA interaction identification by crosslinking and capture (RICC). This combines in vivo psoralen-mediated crosslinking and specific HSUR2 capture, using biotinylated probe hybridization, with high-throughput sequencing (seq) to identify crosslinked RNAs ( Fig. 2a and Extended Data Fig. 2a) . By comparing pulldowns from RNA samples prepared from HVS-transformed marmoset T cells with those prepared from cells in which HSUR2 expression was knocked down before crosslinking by transient transfection with HSUR2 antisense oligonucleotide (ASO) 7 (Extended Data Fig. 2b ), we were able to identify RNAs crosslinked to HSUR2. RICC-seq identified 74 transcripts that were significantly (P ≤ 0.05) enriched in HSUR2 pulldowns in all three replicates (Supplementary Table 1 ). Most transcripts targeted by HSUR2 correspond to mRNAs that code for cellular proteins, though a small subset of them encodes viral proteins (Fig. 2b) . Ingenuity pathway analyses of HSUR2 targets, which include the Fas cell surface death receptor (FAS) 17 , the tumour suppressor retino blastoma (RB1) 18 , and interferon-γ (IFN-γ ) 19 , revealed enrichment of genes involved in cell cycle regulation, apoptosis, and immune response (Fig. 2c and Supplementary Table 2 ), all of which are relevant to HVS infection. These results suggest a possible role for HSUR2 in the regulation of these processes in virally transformed cells, and also provide confidence in RICC-seq as a method for detecting HSUR2 targets.
We hypothesized that HSUR2-mediated recruitment of miR-142-3p and miR-16 would repress HSUR2 targets, primarily through mRNA destabilization 20 . Transient knockdown of HSUR2 in virally transformed marmoset T cells correlated with higher levels of HSUR2 target mRNAs (Fig. 2d) . No changes were observed for the same target Letter reSeArCH mRNAs when an HSUR2 ASO was transfected into marmoset T cells that had been transformed with a mutant version of HVS that lacks HSUR1 and HSUR2 7, 21 (Extended Data Fig. 3 ), which suggests that HSUR2 is specifically involved in regulating these target mRNAs. Ectopic expression of HSUR2, together with other HSURs and HVS miRNAs, in GSML cells (a B cell line derived from a natural host of HVS, Saimiri sciureus) confirmed the repressive role of this viral snRNA on target mRNAs (Extended Data Fig. 4 ). Transient transfection of a vector expressing only the HSUR2 sequence, and not the stem-loop sequence encoding hvsa-miR-HSUR2 miRNAs (Extended Data Fig. 4b ), showed that HSUR2 expression is necessary and sufficient to repress target mRNAs (Fig. 2e) . Moreover, no changes were observed when cells were transfected with a vector carrying only HSUR2 transcriptional signals, suggesting that the downregulation of HSUR2 target mRNAs is not due to the titration of transcription factors. Similar results were obtained when HSUR2 was expressed in the human Burkitt's lymphoma B cell line BJAB (Extended Data Fig. 5 ). Furthermore, when we analysed the levels of proteins encoded by mRNAs that are targeted by HSUR2 in marmoset T cells that were newly transformed with either wild-type HVS (cj137-WT cells) or a 7  7  3  3  3  3  3  3  3  3  3  9 In each case, data shown are representative of three independent experiments. For d and e, dots represent mean values of independent experiments with error bars representing s.d. * * * * P < 0.0001; ***P < 0.001; * * P < 0.01; * P < 0.05; see Supplementary Table 7 for full description of statistics.
Letter reSeArCH mutant HVS lacking only HSUR2 (cj137-Δ HSUR2 cells) (Extended Data Fig. 6 ), the absence of HSUR2 correlated with the upregulation of several of these proteins (Fig. 2f) . These results indicate that RICC-seq successfully identified mRNAs repressed by HSUR2.
HSUR2 associates with argonaute (Ago) proteins 7 . Ago immunoprecipitation experiments (Fig. 3a) revealed that the transient knockdown of HSUR2 resulted in a lower association of HSUR2 target mRNAs with Ago proteins, supporting the hypothesis that interactions between HSUR2 and its target mRNAs result in the recruitment of Ago proteins specifically to these transcripts. Inhibiting miR-142-3p and miR-16 activity with locked nucleic acid (LNA) inhibitors did not affect the expression of HSUR2 (Extended Data Fig. 7a ) or its ability to base-pair with mRNAs (Extended Data Fig. 7b ), but did show that miR-142-3p activity is required for HSUR2-mediated repression of all tested target mRNAs; miR-16 activity is required for the repression of only a subset of HSUR2 targets (Fig. 3b) . HSUR2 expression was not affected by mutations in its miRNA-binding sites (Extended Data Fig. 8a ), though these mutations did affect its ability to destabilize target mRNAs ( Fig. 3c and Extended Data Fig. 8b ). For all tested target mRNAs, HSUR2-mediated repression required a direct interaction between with residues (bold) involved in base-pairing with miRNAs (pink) or in ARE-like sequences. Sample size (n) is indicated below the chart in each case (two-sided t-test). d, e, As in c, but transiently co-transfected with control miRNA or a mutant version of miR-142-3p (miR-142-3p mut ; modified residues in blue) or miR-16 (miR-16 mut ; modified residues in blue) that has complementarity to HSUR2Δ 142-3p or HSUR2Δ 16, respectively (n = 3; two-sided t-test). For a-d, dots represent mean values of independent experiments with error bars representing s.d. * * * P < 0.001; * * P < 0.01; * P < 0.05; see Supplementary Table 7 for full description of statistics. Letter reSeArCH miR-142-3p and HSUR2; cells transfected with a mutant version of HSUR2 that is unable to bind this miRNA (HSUR2Δ 142-3p; Fig. 3c and Extended Data Fig. 8b ) have levels of target mRNAs comparable to those of cells transfected with an empty vector. Similar experiments using an HSUR2 mutant that is unable to bind miR-16 (HSUR2Δ 16) showed that a direct interaction between HSUR2 and miR-16 is required for HSUR2-mediated repression of some (for example, RB1), but not all, HSUR2 targets ( Fig. 3b and Extended Data Fig. 8b ). In the two ARE-like sequences, expression of a mutant version of HSUR2 with U → G substitutions (which are expected to interfere with ARE function 11 ) had a weak, statistically non-significant effect on the levels of the RASA2 and DDX20 mRNAs targeted by HSUR2 (Extended Data  Fig. 8b ). This does not, however, rule out the possibility that the ARE sequences present in HSUR2 play an important role in regulating the stability and/or translation of some of the mRNAs it targets.
The ability of HSUR2Δ 142-3p and HSUR2Δ 16 to repress target mRNAs was restored by the co-transfection of mutant versions of miR-142-3p and miR-16, with seed regions modified to have complementarity to the corresponding mutant HSUR2 (miR-142-3p mut and miR-16 mut ; Fig. 3d , e and Extended Data Fig. 9 ). These results confirm that interactions between HSUR2 and these two cellular miRNAs are necessary for HSUR2-mediated mRNA repression. These results also suggest that HSUR2-mediated repression of target mRNAs is not a consequence of HSUR2 inhibiting miR-142-3p and miR-16 activities, favouring a model in which HSUR2 recruits these miRNAs to its target mRNAs.
HSUR2-mediated mRNA repression plays an important role in viral modulation of apoptosis. Staining cj137-WT and cj137-Δ HSUR2 cells with annexin V and propidium iodide showed that the absence of HSUR2 correlates with a higher percentage of cells undergoing apoptotic cell death (Fig. 4a) . Marmoset T cells that lacked HSUR2 showed increased activity of the key effector caspase-3/7 compared with that observed in cells that expressed the viral snRNA, though both cell lines showed similar levels of activity of the initiator caspase-8 ( Fig. 4b) . In BJAB cells, transient expression of HSUR2 resulted in decreased caspase-3/7 activity on FAS-induced apoptosis ( Fig. 4c ) and on tumour necrosis factor alpha (TNFα )-induced apoptosis (Extended Data Fig. 10a ), confirming a role for this viral snRNA in the regulation of apoptosis. To test whether HSUR2-mediated mRNA repression is necessary for the regulation of apoptosis, we expressed mutant versions of HSUR2 that were unable to bind miR-142-3p and/or miR-16 in BJAB cells, and measured caspase-3/7 activity on induction of apoptosis. Resistance to FAS-induced ( Fig. 4c) and TNFα -induced (Extended Data Fig. 10a ) apoptosis requires the interaction of HSUR2 with both miRNAs. Furthermore, co-transfection of miR-142-3p mut or miR-16 mut restored the ability of HSUR2 mutants to confer resistance to apoptosis 
Relative Caspase 3/7 Activity 0 0.5 Table 7 for full description of statistics.
( Fig. 4d and Extended Data Fig. 10b ). These results suggest that HSUR2 restricts apoptosis by recruiting host miR-142-3p and miR-16 to target mRNAs that encode key apoptotic factors, rather than by affecting the activity of the miRNAs themselves. We have demonstrated that HSUR2 snRNA interacts with specific mRNAs in virally transformed T cells (Fig. 1 ). Psoralen-dependent crosslinking indicates that these interactions occur through basepairing (Fig. 1a) . HSUR2 expression destabilizes target mRNAs (Fig. 2) . Presumably, base-pairing with target mRNAs is required for HSUR2-mediated repression. Further investigation is required to elucidate the mechanism by which HSUR2 is recruited to its target mRNAs. HSUR2-mediated mRNA destabilization requires that HSUR2 binds to miR-142-3p and, in some cases, miR-16 (Fig. 3) , suggesting that HSUR2 functions by recruiting these miRNAs to its target mRNAs (Fig. 4e) . HSUR2-mediated tethering of miRNAs to target mRNAs leads to recruitment of Ago proteins (Fig. 3a) , which promote translational repression and/or degradation, through de-adenylation of the target mRNAs 22 . As HSUR2 is not polyadenylated, its expression is unaffected by associations with Ago proteins 7 (Extended Data Figs 7a, 8a). HSUR2 is more abundant than target mRNAs, but less abundant than miR-142-3p and miR-16 (Supplementary Table 3 ). This stoichiometry is probably important in ensuring effective miR-142-3p-dependent and miR-16-dependent HSUR2-mediated mRNA repression 23 . Disruption of HSUR2 ARE-like sequences did not have a statistically significant effect on target mRNA destabilization ( Fig. 3c and Extended Data Fig. 8b ). These sequences, as well as the recruited miRNAs, might modulate the translation of target mRNAs 24 . Our results uncover a role for a viral Sm-class RNA in the regulation of gene expression after pre-mRNA processing, a role reminiscent of those performed by the bacterial Hfq-associated regulatory RNAs (structurally related to Sm-class RNAs) that regulate the stability and translation of target mRNAs 25 . Given that viruses often co-opt factors from their hosts, it is conceivable that similar non-coding RNAs exist in host cells, and act to regulate gene expression in a similar fashion 26 ; further investigation is required to test these hypotheses.
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Plasmids. For selection of transfected cells on the basis of expression of GFP by FACS, a fragment containing the human cytomegalovirus intermediate-early enhancer/promoter, the GFP coding region, and the polyadenylation signal of the simian virus 40 was generated by PCR using pEGFP-C2 (Clontech) as a template, and inserted between the KpnI and XhoI sites of pBluescript II SK+ (Stratagene) to generate the plasmid pBS-GFP (referred to as 'empty vector' in Figs 2e and 3, and Extended Data Figs 4d, 5, 8, and 9). For expression of HSURs and HVS miRNAs, a genomic fragment including positions + 1,444 and + 3,504 of the genome of HVS A11 (GenBank: X64346.1) was inserted between the SalI and BamHI sites of pBS-GFP to generate the plasmid pBS-GFP-H1-5 for expression of HSUR1, HSUR2, and HSUR5, together with hvsa-miR-HSUR2 and hvsa-miR-HSUR5 miRNAs (HSURs1-5, Extended Data Fig. 4a) . A genomic fragment including positions + 4,613 and + 6,945 of the genome of HVS A11 was inserted between the SalI and BamHI sites of pBS-GFP to generate the plasmid pBS-GFP-H3-7 for expression of HSUR3, HSUR4, HSUR6, and HSUR7, together with hvsa-miR-HSUR4 miRNAs (HSURs3-7, Extended Data Fig. 4a ). For expression of HSUR2 only, and not hvsa-miR-HSUR2 miRNAs, a fragment of HVS A11 genome including positions + 2,344 to + 2,726 was inserted between the EcoRI and BamHI sites of pBS-GFP to generate the plasmid pBS-GFP-HSUR2 (Extended Data Fig. 4b ). The plasmid pBS-GFP-Δ HSUR2 (provided by S. Camolotto) containing only the HSUR2 promoter and enhancer sequences, and not the HSUR2 sequence (Extended Data Fig. 4b ), was generated by inserting an HVS A11 genomic fragment including positions + 2,486 to + 2,726 between the EcoRI and BamHI sites of pBS-GFP. Mutant versions of HSUR2 (plasmids pBS-HSUR2Δ 142-3p, pBS-HSUR2Δ 16, pBS-HSUR2Δ ARE, and pBS-HSUR2Δ 142-3p/16) were obtained by site-directed mutagenesis using a QuickChange site-directed mutagenesis kit (Stratagene), and confirmed by sequencing. Recombinant HSV. The bacmid constructs HVS-BAC-GFP-WT and HVS-BAC-GFP-Δ HSUR2 were generated by en passant mutagenesis 27,28 . We generated a plasmid that contained the first ~ 7 kb of the HVS A11 genome by inserting an HVS A11 genomic fragment generated by overlapping PCR with two fragments (one fragment including positions + 22 to + 2,354 of the HVS A11 genome, and a second fragment including positions + 2,547 to + 7,249). The generated fragment, which lacked both HSUR2 and the HSUR2 promoter sequence required for expression of hvsa-miR-HSUR2 miRNAs 29 , was inserted between the SalI and BamHI sites of pBluescript II SK+ to generate the plasmid pBS-7.4Δ HSUR2. A unique NcoI site was generated at a position corresponding to + 3,664 of the HVS A11 genome, by performing site-directed mutagenesis on both pBS-7.4Δ HSUR2 and pBS- 7.4 29 to generate the plasmids pBS-7.4Δ HSUR2-Nco and pBS-7.4-Nco. A PCR amplicon containing the kanamycin resistance gene, the I-SceI restriction site and a 50-bp duplication of the HVS A11 genomic sequence was generated using the pEPkanS2 vector 27 (provided by K. Tischer), and inserted into the NcoI site of pBS-7.4Δ HSUR2-Nco and pBS-7.4-Nco to generate the plasmids pBS-7.4Δ HSUR2-Nco-Kan and pBS-7.4-Nco-Kan, respectively. PCR-amplified fragments encompassing positions + 65 to + 4,637 of the HVS A11 genome were generated using pBS-7.4Δ HSUR2-Nco-Kan and pBS-7.4-Nco-Kan as templates (Extended Data Fig. 6a) , and recombined into the bacmid HVS-BAC-GFP 30 (provided by A. Whitehouse) in GS1783 cells (a gift from G. Smith) as previously described 28 .
The bacmid HVS-BAC-GFP carries the SacI deletion 31 that removes part of the saimiri transforming protein-A coding region, together with the genes encoding HSUR1, HSUR2, and HSUR5, hvsa-miR-HSUR2 and hvsa-miR-HSUR5 miRNAs, and part of viral dihydrofolate reductase (vDHFR) (Extended Data Fig. 6a ). Viruses generated with HVS-BAC-GFP are therefore unable to transform cells 30, 31 . Recombinants were selected on chloramphenicol-kanamycin plates. The scarless removal of the kanamycin cassette was achieved by induction of I-SceI expression during the second Red recombination step, through arabinose induction; this generated the bacmids HVS-BAC-GFP-WT and HVS-BAC-GFP-Δ HSUR2. Positive clones were screened by PCR, and analysed by restriction endonuclease (Extended Data Fig. 6b ) and sequencing. Figs 1, 3) , were grown in RPMI-1640 medium (ThermoFisher Scientific) supplemented with 20% fetal bovine serum, 100 units per ml penicillin, 100 μ g ml −1 streptomycin, 2 mM glutamax (ThermoFisher Scientific), 1 mM sodium pyruvate (ThermoFisher Scientific) and 0.001% β -mercaptoethanol (Sigma Aldrich). Epstein-Barr virus (EBV)-transformed B-lymphoblast GSML cells 34 (ATCC-CRL-2699) and BJAB cells (a gift from J. Steitz) were not authenticated and were grown in RPMI-1640 medium supplemented with 10% fetal bovine serum, penicillin, streptomycin, sodium pyruvate and glutamax. BJAB cells were used for apoptosis assays (Fig. 4 and Extended Data Fig. 10 ) because they express miR-142-3p and are not transformed by Epstein-Barr virus. All cell lines were routinely tested for the presence of mycoplasma. pactamycin (Sigma Aldrich) were analysed on 12-ml linear 15-50% sucrose gradients prepared in polysome buffer (20 mM Tris-HCl, pH 7.5, 150 mM KCl, 10 mM MgCl 2 and 100 μ g ml −1 cycloheximide (Sigma Aldrich)), and equilibrated at 4 °C for 3 h. In brief, cells were collected, centrifuged, and suspended in 20 ml complete RPMI-1640 medium with 100 μ g ml −1 cycloheximide. Cells were incubated at 37 °C and 5% CO 2 for 25 min and centrifuged. Cells were suspended in four volumes of hypotonic lysis buffer (5 mM Tris-HCl, pH 7.5, 1.5 mM KCl, 10 mM MgCl 2 , 5 mM DTT, 0.5% Triton X-100, 0.5% sodium deoxycholate, 10 μ g ml −1 digitonin, 10 mM ribonucleoside vanadyl complex (New England Biolabs) preheated at 65 °C and 100 μ g ml −1 cycloheximide). Cells were vortexed and passed three times through a 25-gauge needle and then three times through a 27.5-gauge needle. The extracts were clarified at 17,000g for 10 min at 4 °C and heparin (ThermoFisher Scientific) was added to a final concentration of 1 mg ml −1 . Where indicated, EDTA was added to the clarified extract to a final concentration of 50 mM and incubated on ice for 20 min. Extract samples of 300 μ l were layered on top of duplicate sucrose gradients and centrifuged at 150,000g on a Beckman SW41 rotor for 2 h at 4 °C. The sedimentation profile of one of the gradients was determined using a 65% sucrose pump at a constant flow rate of 1.5 ml min −1 linked to an ISCO UA-6 254-nm ultraviolet detector equipped with a chart recorder set at 60 cm h −1 and 1 absorbance unit full scale. The second gradient was fractionated (0.5 ml per fraction) and the RNA was purified by acid phenol-chloroform extraction and 3 M sodium acetate-ethanol precipitation, and then analysed by northern blot. Northern blotting. RNA from each fraction of the sucrose gradients was suspended in 20 μ l 1× DNase reaction mixture: 2 μ l 10× DNase reaction buffer, 0.4 units RNase-free DNase I (New England Biolabs) and 17.8 μ L H 2 O, and incubated at 37 °C for 30 min. The volume of each sample was taken to 0.5 ml with H 2 O, and the RNA was re-purified by acid phenol-chloroform extraction and sodium acetate-ethanol precipitation. RNA samples were then suspended in 20 μ l 2 mM Tris-HCl, pH 7.5, 8 M urea and 20 mM EDTA and heated at 65 °C before loading onto a 14% denaturing polyacrylamide gel. Gels were run at 10 W in 1× TBE and transferred onto a Zeta-Probe nylon membrane (Bio-Rad) for 30 min at 1 A using a semi-dry blotting unit (Fisher Biotech). The membranes were prehybridized at 42 °C in ExpressHyb hybridization solution (Clontech) for at least 1 h. Hybridization of 32 P-labelled probes to HSUR2, U2 and U6 was performed in ExpressHyb solution overnight at 42 °C. Hybridization of 32 P-labelled probes to miR-142-3p, miR-16 and miR-21 was performed overnight at 30 °C. Blots were washed once with 2× saline sodium citrate (SSC) buffer, 0.1% sodium dodecyl sulfate (SDS) for 15 min at room temperature, followed by either a wash with 1× SSC, 0.1% SDS for 15 min at room temperature (miR-142-3p, miR-16, and miR-21 probes) or a wash with 0.5× SSC, 0.1% SDS for 15 min at room temperature (HSUR2, U2, and U6 probes). Membranes were wrapped in Saran Wrap and exposed to a phosphorImager screen (GE Healthcare). To detect β -actin mRNA in the polysome gradient fractions, RNA was suspended in 25 μ l of 20 mM 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7, 15% formaldehyde, 50% deionized formamide and 20 mM EDTA, heated at 95 °C for 15 min, placed on ice and loaded onto 1.2% agarose-formaldehyde gels. The gels were run at 100 V in 20 mM MOPS, pH 7, 2.6% formaldehyde and transferred overnight onto nylon membranes through capillarity. The membranes were stained with 0.02% methylene blue in 0.4 M sodium acetate and 0.4 M acetic acid, and destained in H 2 O. Blots were prehybridized in ExpressHyb solution at 42 °C for 4 h and hybridized with 32 P-labelled probe to β -actin mRNA overnight at 80 °C. The membranes were washed with 2× SSC, 0.1% SDS for 15 min at room temperature followed by a wash with 0.5× SSC, 0.1% SDS for 15 min at room temperature. Membranes were wrapped in Saran Wrap and exposed to a phosphorImager screen. Probe radiolabelling. Radiolabelled probes were prepared in 20-μ l reactions, containing 10 pmoles ASO to HSUR2, U2, U6, miR-142-3p, miR-16 or miR-21, 10 units of T4 polynucleotide kinase (New England Biolabs) and 151.5 μ Ci of [γ - , PerkinElmer) and incubated at 37 °C for 1 h. Unincorporated isotope was removed by centrifugation using Mini Quick G-25 gel filtration columns, according to the manufacturer's protocol (Roche). Radiolabelled probes were eluted in a volume of 50 μ l H 2 O, and 10 μ l of eluted radiolabelled probe was used in each hybridization experiment. A β -actin probe was labelled using 50 μ Ci [α -32 P]dCTP and Klenow DNA polymerase for 15 min, using the DecaPrime II kit according to the manufacturer's instructions (Ambion). A 10-μ l aliquot of the radiolabelled probe was taken to a volume of 100 μ l with 10 mM EDTA, pH 8 and incubated at 95 °C for 10 min. The labelled probe was then added directly without further purification to the prehybridized membranes. Immunoblotting. Marmoset cj137-WT and cj137-Δ HSUR2 cells were collected and stained with 100 ng ml −1 2-(4-amidinophenyl)-1H-indole-6-carboxamidine (DAPI) and FACS-sorted in a BD FACSAria-II cell sorter (BD Biosciences) equipped with a UV laser, at the University of Utah Flow Cytometry Core. Live DAPI-negative cells were collected and total cell lysates were prepared in Glo Lysis buffer (Promega) containing complete protease inhibitors (Roche), 10 mM N-ethylmaleimide (Sigma Aldrich) and 1 mM phenylmethylsulfonyl fluoride (Fluka BioChemika). Cj319-WT and cj319-Δ 2a cells were collected, washed with phosphate-buffered saline (PBS) and directly lysed for analysis as described above. The protein concentration of the lysates was determined with the Coomassie Plus Protein Assay reagent (ThermoFisher Scientific). Lysates were boiled with 1× SDS-PAGE sample buffer, and 15 or 20 μ g total protein was separated on 10% high Tris polyacrylamide gels (0.75 M Tris base) using high Tris running buffer (50 mM Tris base, 193 mM gycine, 0.1% SDS). Proteins were transferred onto nitrocellulose membranes, probed with the indicated antibodies and visualized by enhanced chemiluminescence, according to standard protocols. Transfections. Ten million cj319-WT or cj319-Δ 2a cells were nucleofected with control (complementary to GFP coding sequence) or HSUR2 chimaeric ASO (see RICC-seq described below) (Integrated DNA Technologies) as described above, using Amaxa's human T-cell kit (Lonza) and program X-001 in a nucleofector 2b device. Twenty-one hours after transfection the cells were collected, washed with PBS and stored in TRIzol (ThermoFisher Scientific) at − 80 °C until used. GSML and BJAB cells were nucleofected using 5 × 10 6 and 3 × 10 6 cells, respectively, per nucleofection, with Amaxa's kit V (Lonza) and program T-020, combined with 3.4 μ g pBS-GFP, 1 μ g vector that encoded pBS-GFP-HSUR2 (and mutant variants of HSUR2), or 1 μ g pBS-GFPΔ HSUR2. In experiments in which GSML cells or BJAB cells were co-transfected with miR-142-3p mut or miR-16 mut (Integrated DNA Technologies), 50 pmoles mutant miRNA or 50 pmoles control siRNA-A (Santa Cruz Biotechnology) were added to the nucleofection reaction. To test the effect of LNA miRNA inhibitors on HSUR2-mediated repression of HSUR2 targets, pBS-GFP or pBS-GFP-HSUR2 plasmid was co-transfected with: 100 pmoles control LNA (miRCURY LNA TM microRNA inhibitor negative control A); 50 pmoles miRCURY LNA miRNA inhibitor against hsa-miR-142-3p (Exiqon), with 50 pmoles control LNA; 50 pmoles miRCURY LNA miRNA inhibitor against hsa-miR-16 (Exiqon), with 50 pmoles control LNA; or 50 pmoles each of both miR-142-3p and miR-16 LNA inhibitors. Transfections of GSML cells with pBS-GFP-H1-5 and pBS-GFP-H3-7 were performed using 5 μ g of plasmid, with 3.4 μ g pBS-GFP or 5 μ g each of both pBS-GFP-H1-5 and pBS-GFP-H3-7. In all the experiments described above, transfected GSML cells or BJAB cells were grown for 18-21 h after nucleofection and FACS-sorted on a BD FACSAria-II cell sorter equipped with a 488-nm laser (525/50 filter set) for GFP-positive cells. Cells that were collected expressed a mid-range level of GFP (arbitrary fluorescence of 10 3 -10 5 within the GFP window; DAPI staining in initial experiments showed that cells expressing GFP beyond 10 5 were necrotic, and these were therefore discarded and excluded from further analysis). Immediately after sorting, cells were centrifuged, suspended in 100 μ l of culture medium and stored in TRIzol at − 80 °C until used.
Quantitative RT-PCR (qRT-PCR).
Total RNA was isolated from cj319-WT, cj319-Δ 2a, GSML, or BJAB cells with TRIzol according to the manufacturer's instructions. The TRIzol-purified total RNA was suspended in 85 μ l of water and 10 μ l of 10× DNase I buffer, treated with 10 units RNase-free DNase I (New England Biolabs) at 37 °C for 30 min and re-purified with acid phenol-chloroform extraction, followed by sodium acetate-ethanol precipitation. cDNA was synthesized in 20-μ l reactions using the High Capacity cDNA Reverse Transcription Kit with MultiScribe Reverse Transcriptase (Applied Biosystems) using 600-900 ng total RNA treated with DNase I, and random primers. Subsequently, quantitative PCR (qPCR) was performed in 8-μ l reactions using primers (Supplementary  Table 4 ) at 0.5 μ M, cDNA diluted at ratios 1:3-1:7.5 (depending upon the input of total RNA used in the cDNA synthesis reaction as described above) and KAPA SYBR green (KAPA Biosystems) in a Roche 480 LightCycler (95 °C for 5 min, 1 cycle; 95 °C for 10 s, 60 °C for 10 s and 72 °C for 10 s, 55 cycles followed by a melting curve of the reaction product from 65 °C to 97 °C with a ramp rate of 0.11 °C s
−1
). qPCR primers were designed using Primer3Plus and tested using cDNA prepared from 900 ng DNase-treated total RNA and diluted at ratios 1:5-1:5,000. All reactions were performed at least four times in each independent experiment. C t values were determined using the ' Abs quant/2nd derivative max' function of the LightCycler. Relative mRNA levels of HSUR2 targets were calculated using the ∆∆ −
2
C t method 35 , dividing the ∆ − 2 C t of the HSUR2 target in the treated sample (combined with HSUR2 and so on) by the ∆ − 2 C t of the HSUR2 target in control sample (combined with empty vector or Δ HSUR2). For normalization, the C t values of 18S ribosomal RNA were subtracted from the C t values of HSUR2 targets to calculate Δ C t . Estimation of the number of molecules of HSUR2 and HSUR2 target mRNAs in wild-type and ΔHSUR2 marmoset T cells. Sequences of select HSUR2 targets were amplified from marmoset T-cell cDNA by PCR using Taq polymerase and pairs of primers (listed in Supplementary Table 4), and introduced into the pCR2.1-TOPO vector by TA-cloning (Invitrogen). Plasmids encoding sequences of HSUR2 targets were purified, quantified and used to prepare 1:10 serial dilutions in H 2 O from 100 pg μ l −1 to 100 ag μ l −1
. Two-microlitre samples of each dilution were then used in qPCR reactions, using KAPA SYBR green as described above to generate standard curves (log (number of molecules) versus C t ) for each target. A standard curve for HSUR2 was generated using 1:10 serial dilutions of pBS-HSUR2Δ miR in H 2 O as template. Total RNA from 4 × 10 6 wild-type or 3.05 × 10 6 Δ HSUR2 marmoset T cells was isolated with TRIzol, and 900 ng were used to synthesize cDNA as described above. The resulting cDNAs were diluted 1:5 for analysis of HSUR2 targets, and diluted 1:1,000 for analysis of HSUR2 in H 2 O. Subsequently, qPCR was performed as described above. The resulting C t values were used to estimate the number of molecules for HSUR2 and for HSUR2 targets, using the previously generated standard curves. Analysis of mRNAs co-immunoprecipited with Ago proteins. Thirty to forty million cj319-WT cells were transfected with control or HSUR2 ASO as described above and used to prepare whole-cell extracts in 0.35-0.4 ml NET-2 buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Nonidet-40), containing complete protease inhibitors, 1 mM PMSF and 5 μ l of RNaseOUT (ThermoFisher Scientific). Extracts were sonicated on ice three times for 10 s each. Lysates were cleared by centrifugation at 16,000g for 10 min at 4 °C. Aliquots equal to 10% of each lysate were saved and immediately stored in 1 ml TRIzol. Rabbit anti-mouse IgG (ThermoFisher Scientific) was immobilized on Protein A Sepharose 4 Fast Flow beads (GE Healthcare) in bulk overnight at 4 °C and aliquoted into corresponding tubes before the last wash to guarantee that all samples were incubated with the same amount of antibody. The remaining 90% fraction of each lysate was incubated with 5 μ l anti-PAN-Ago antibodies, or normal mouse serum (Sigma Aldrich), and 30 μ l rabbit anti-mouse IgG, with continuous rotation for 4 h at 4 °C. Samples were washed four times with NET-2 buffer containing protease inhibitors, and the RNA immunoprecipitation (RIP) fractions were collected by centrifugation and stored immediately in TRIzol at − 80 °C.
For RNA purification and cDNA synthesis, the total RNA in TRIzol from input and RIP fractions was isolated according to the manufacturer's instructions using 20 μ g glycogen during the precipitation step. Total RNA was resuspended in 15 μ l water and used for cDNA synthesis as described above, except that 1.5 μ l of each input fraction (1% of the total) and 14.2 μ l of each RIP fraction was used per 20-μ l reaction.
For immunoprecipitated mRNAs, qPCR of HSUR2 targets was performed as described above using cDNAs from input and RIP fractions, diluted 1:5 in H 2 O. The C t values of HSUR2 targets were normalized to the input RNA fraction C t values according to the following equation:
− log 2 (input dilution factor))). As 1% of each input fraction was used to synthesize cDNA, log 2 100 = 6.644. The normalized RIP-fraction C t value was then adjusted for the normalized background (normal mouse serum reaction (NS)) fraction C t value as follows:
The fold enrichment, above the sample specific background, of each HSUR2 target in the RIP fraction was then calculated as
The fold enrichment of the control ASO relative to HSUR ASO was calculated as
Letter reSeArCH Apoptosis assays. Growing cultures of cj137-WT and cj137-Δ HSUR2 cells were collected and layered on top of 10-ml cushions of Histopaque-1077 (Sigma Aldrich) to remove cell debris. The cells were centrifuged at 400g for 30 min at room temperature, and cells at the interface were collected, washed, suspended in complete medium, and counted. Cells were seeded at a density of 500,000 cells per ml and grown for two weeks. Cells were then collected, washed in ice-cold PBS, centrifuged and suspended at a density of 10 6 cells per ml in 100 μ l annexinbinding buffer (10 mM HEPES, pH 7.4, 140 mM NaCl and 2.5 mM CaCl 2 ). Cells were stained for 15 min at room temperature with Alexa Fluor 647 annexin V conjugate (1:20 dilution, Life Technologies) and 1 μ g ml −1 propidium iodide (Life Technologies). Samples were diluted with 400 μ l annexin-binding buffer and placed on ice. Data were acquired on a BD FACSCanto (BD Biosciences) flow cytometer using the 488-nm (685/40 filter set) and 640-nm (670/30 filter set) lasers. Alternatively, cj137-WT and cj137-Δ HSUR2 cells were stained with 100 ng ml −1 DAPI, and live DAPI-negative cells were FACS-sorted directly into a 96-well plate at a density of 20,000 cells per well. Caspase activity was then measured with the Caspase-Glo 3/7 and Caspase-Glo 8 reagents, according to the manufacturer's instructions (Promega). Caspase 3/7 activity was also measured for BJAB cells transiently expressing HSUR2 or HSUR2 variants (Fig. 4 and Extended Data Fig. 10 ).These BJAB cells were transiently transfected with pBS-GFP-HSUR2, pBS-GFP-Δ HSUR2, pBS-GFP-HSUR2Δ 142-3p, pBS-GFP-HSUR2Δ 16, or pBS-GFP-HSUR2Δ 142-3p/16, and GFP-positive cells were FACS-sorted and suspended in culture medium to a density of 400,000 cells per ml; 100 μ l of this suspension was seeded per well onto a 96-well plate. The cells were then incubated with 100 ng ml −1 recombinant soluble Fas ligand (PeproTech) or 100 ng ml −1 TNFα (Sigma Aldrich) for 19 h at 37 °C. Caspase 3/7 activity was then assayed as described above. RICC-seq: in vivo RNA-RNA crosslinking. Two sets of three independent samples of 6 × 10 7 cj319 cells per sample were treated with chimaeric ASOs (the oligonucleotides are 20-nt long, contain backbone phosphorothioate linkages to increase stability, and have five nucleotides on each end substituted with 2′ -O-methoxyethyl ribonucleotides 7, 36 ) directed to GFP (5′ -UCACCTTCACCCTCTCCACU -3′ ) (control HSUR2-positive sample), or with an ASO directed to HSUR2 (5′ -AAG CGATACCTCGTGUGUGA -3′ ), which specifically targets HSUR2 for degradation (HSUR2-negative sample) 7 (Extended Data Fig. 2 ). Cells were transfected (10 7 cells per nucleofection) with 1 nmol ASO by applying three 1,700-V pulses for 10 ms each (Neon System, ThemoFisher Scientific). Cells were then plated at a density of 1 × 10 6 cells per ml, grown at 37 °C and 5% CO 2 for 24 h, and collected. Cells from each sample were pooled, washed with PBS and suspended in 1 ml PBS containing 200 μ g ml −1 4′ -aminomethyl-4,5′ ,8-trimethylpsoralen (Cayman Chemical), crosslinked as described 7 , collected, and fractionated in 100-μ l samples. One hundred microlitres of 6 M guanidinium hydrochloride was added to each sample followed by 20 μ l of a 20 mg ml −1 solution of RNase-free proteinase K (Ambion) and 5 μ l of 20% SDS. Samples were incubated at 65 °C for 1 h. One millilitre of TRIzol was added to each sample and then stored at − 80 °C. RICC-seq: polyA+ RNA purification. Total RNA was purified from control HSUR2-positive and HSUR2-negative samples in TRIzol, according to the manufacturer's protocol. PolyA+ RNA was isolated using oligo d(T)25 magnetic beads (New England Biolabs). In brief, purified total RNA was suspended in 600 μ l H 2 O and heated to 65 °C for 5 min. One volume of 2× binding buffer (40 mM Tris-HCl, pH 7.5, 1 M NaCl, 1% SDS, 2 mM EDTA, 10 mM DTT) was added to each sample and mixed with 250 μ l of oligo d(T)25 magnetic beads. Samples were incubated with continuous rotation for 30 min at room temperature. The beads were washed twice for 1 min with 1 ml of wash buffer 1 (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.1% SDS, 1 mM EDTA, 5 mM DTT) and then once with 1 ml of wash buffer 2 (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1 mM EDTA). The beads were then incubated with 1 ml of low salt buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM EDTA) for 1 min at room temperature. PolyA+ RNA was eluted from the beads with 500 μ l of elution buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA) at 50 °C for 5 min with continuous agitation. PolyA+ RNA was precipitated by adding 50 μ l of 3 M sodium acetate, pH 5.2, 5 μ l of a 10 mg ml −1 solution of glycogen and 1 ml of 100% ethanol, and incubated overnight at − 20 °C. RICC-seq: capture of HSUR2 with biotinylated ASO. PolyA+ from HSUR2-positive or HSUR2-negative samples was suspended in 500 μ l H 2 O, heated to 95 °C for 3 min and placed on ice. Five hundred pmoles of a biotinylated HSUR2 ASO (5′ -GGTTTTTAAATATGTACACCC-3′ -Bio) was added to each sample. The samples were incubated at 65 °C for 5 min and 500 μ l of 2× binding buffer (20 mM Tris-HCl, pH 7.5, 1 M NaCl, 2 mM EDTA, 0.1% SDS) heated at 65 °C was added to each sample. One hundred microlitres from each sample were saved as 'PolyA+ input' samples and stored in 1 ml TRIzol at − 80 °C until used. The remaining 900 μ l from each sample was incubated for 4 h at room temperature with continuous rotation. After annealing was complete, 125 μ l of MPG streptavidin magnetic beads (PureBiotech) was added to each sample and incubated overnight at 4 °C. The beads were washed twice with 1× binding buffer (10 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1 mM EDTA, 0.05% SDS) and twice with 1× wash buffer (10 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM EDTA, 0.05% SDS). Bound RNA was recovered by adding 1 ml TRIzol to the beads. RNA was purified from both the input and HSUR2 ASO-treated samples, according to the manufacturer's protocol. RICC-seq: library preparation and high-throughput sequencing. Purified RNA samples were suspended in 25 μ L H 2 O and placed on a glass plate covered with parafilm on ice. The AMT crosslinks were reversed by directly irradiating the samples at 254 nm for 10 min. The samples were collected and taken to a volume of 300 μ l with H 2 O. RNA was precipitated by adding 40 μ g glycogen, 30 μ l of 3 M sodium acetate, pH 5.2 and 900 μ l of 100% ethanol. Samples were incubated overnight at − 20 °C. The RNA was recovered by centrifugation, washed and suspended directly in 19.5 μ l 'Fragment, Prime, Finish' (FPF) mix from the TruSeq Stranded mRNA LT kit, to prepare libraries for deep sequencing according to the manufacturer's protocol (Illumina). HiSeq 50 Cycle single-read sequencing was performed by the High Throughput Genomics Core Facility at the Huntsman Cancer Institute (University of Utah) on an Illumina HiSeq 2500 instrument. RICC-seq: bioinformatic analyses. A reference sequence was created using a marmoset genomic sequence (calJac3 assembly), Saimiriine herpesvirus 2 (GenBank: X64346.1) and splice junction sequences. The splice junction sequences were generated using USeq (v8.8.8) MakeTranscriptome using default settings. CalJac3 Ensembl build 80 and X64346.1 annotations were used in MakeTranscriptome. Reads were aligned to the reference sequence using Novoalign (2.08.03) allowing up to 50 alignments and removing adaptor sequences. The resulting alignments were then run through USeq SamTranscriptomeParser using default settings to convert splice alignments back to genomic space and to remove low quality reads. Reads aligning to multiple locations in the genome were removed. USeq DefinedRegionDifferentialSeq was used to count the number of aligned reads to each gene. The only reads that were counted were those aligning to the opposite strand of the annotation. Genes with fewer than ten reads across all replicates were thrown out. The resulting read counts were then run in DESeq (v1.4.5) to determine which genes were differentially expressed in each condition, using default settings. Genes that were significantly enriched (BenjaminiHochberg adjusted P value < 0.05, log 2 fold change > 0) in the HSUR2-positive pulldown versus HSUR2-negative pulldown, and in the HSUR2-positive pulldown versus HSUR2-positive input, were used in further analyses (Supplementary Table 1 ). Significantly enriched genes were analysed by Ingenuity Pathway Analysis version 24718999 (IPA, Qiagen) using common name, and compared against the ingenuity knowledge base. All pathways that showed Fisher's Exact Test P values < 0.05 (not adjusted for multiple hypothesis testing) are shown in Supplementary Table 2, whereas significant pathways that are relevant for HVS infection are shown in Fig. 2c . Statistical analyses. No statistical methods were used to predetermine sample size, nor were the experiments randomized or the investigators blinded to sample allocation during experiments and evaluation of experimental results. 'Biological replicates' (n), indicated in figures and figure legends, refers to the number of independent experiments performed. The number of independent experiments was chosen to allow for statistical significance. Statistical analysis was performed using Graphpad Prism 7. Data were analysed for the presence of outliers using the ROUT method (Q = 10%). Statistical analysis of biological replicates shown in Fig. 2d and Extended Data Fig. 3 was performed with Student's t-tests corrected for multiple comparisons with the Holm-Sidak method (alpha = 0.05), after using Bartlett's test (https://home.ubalt.edu/ntsbarsh/business-stat/ otherapplets/BartletTest.htm) to determine whether the variance of the different groups was significantly different. Two-sided P values of biological replicates shown in Figs 2e, 3, and Extended Data Figs 4d, 5, 8, and 9 were obtained with Student's t-tests, compared to the control samples set at 1.0. When outliers were present, the samples were compared with Wilcoxon's signed rank test. The pairwise comparisons made between experimental groups and controls shown in Fig. 4 and Extended Data Fig. 10 were performed using unpaired Student's t-test, with or without Welch's correction for unequal variances, after using Bartlett's test to determine whether the variance of the different groups was significantly different. When outliers were present (ROUT method, Q = 10%), the paired groups were compared using the non-parametric Mann-Whitney test. For all data presented, see Supplementary Table 7 for the specific test used, the exact number of replicates and exact P values. Data availability. Source data for all figures in this article are included in its Supplementary Information. The described RNA-seq data have been deposited in the Gene Expression Omnibus under accession number GSE79082. Further data that support the findings of this study are available from the corresponding author upon reasonable request.
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Extended Data Figure 5 | HSUR2 represses target mRNAs in the human B cell line BJAB. BJAB cells were transiently transfected with plasmids pBS-GFP (empty vector, white bars), pBS-GFP-HSUR2 (HSUR2), or pBS-GFP-Δ HSUR2 (Δ HSUR2), FACS-sorted for GFP expression, and analysed as described in Fig. 2e (two-sided t-test) . Dots represent mean values of independent experiments with error bars representing s.d. Sample size (n) is indicated below the chart in each case. * * * P < 0.001; * * P < 0.01; * P < 0.05; see Supplementary Table 7 for full description of statistics.
Extended Data Figure 7 | Ablation of miR-142-3p and miR-16 expression does not affect HSUR2 expression or its ability to basepair with mRNAs. a, Northern blot analysis of total RNA isolated from GSML cells treated as described in Fig. 3a . U6 snRNA provides a loading control. b, AMT-mediated RNA-RNA crosslinking and polyA+ selection performed as in Fig. 1a , on HVS-transformed marmoset T cells transiently transfected with the indicated LNA inhibitors. Figure 8 | Interaction of HSUR2 with miR-142-3p and miR-16 is required for HSUR2-mediated mRNA repression. a, Northern blot analysis of total RNA isolated from GSML cells that were treated as described in Fig. 3c . U6 snRNA provides a loading control. b, As in Fig. 3c , for the other targets of HSUR2. Analysed by two-sided t-test in all cases, except for STAG1, RBM7, RASA2, DDX20, and DDX5 (HSUR2Δ 142-3p/16 versus empty vector in all cases), for which a twosided Wilcoxon signed rank test was used. Dots represent mean values of independent experiments with error bars representing s.d. Sample size (n) is indicated below the chart in each case. * * * * P < 0.0001; * * * P < 0.001; * * P < 0.01; * P < 0.05; see Supplementary 
Extended Data

Data exclusions
Describe any data exclusions. Quantitative real-time PCR experiments were performed in quadruplicate. Individual data points were excluded when melting curve indicated than more than one product was amplified in a particular well, or when no amplification was observed in a particular well.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful for all experiments described in this manuscript.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Experiments were not randomized.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators were not blinded to sample allocation during experiments and evaluation of experimental results.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
